Literature DB >> 3116878

[Acute liver and kidney failure following sorbitol infusion in a 28-year-old patient with undiagnosed fructose intolerance].

S Locher1.   

Abstract

In connection with nephrectomy fatal liver and renal failure occurred after infusion of 50 g sorbitol in a 28 years old patient with undiagnosed fructose intolerance. A marked hypoglycemia and lactacidosis, an increase in uric acid, an acute liver failure with breakdown of excretory and synthetic function and disorder of hemostasis were typical of fructose/sorbitol infusion in hereditary fructose intolerance. Under adequate diet, as indicated in our case, HFI could be undiagnosed up to adult age. Therefore, fructose intolerance should be excluded by anamnesis before infusion of fructose/sorbitol. In unknown anamnesis (unconsciousness) fructose/sorbitol containing infusions should not be used. Fructose/sorbitol containing infusions should not be given routinely, but only with certain indication.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3116878

Source DB:  PubMed          Journal:  Anasth Intensivther Notfallmed        ISSN: 0174-1837


  4 in total

1.  Declaration of fructose and fructose-related adverse effects in commercial drug preparations in European countries.

Authors:  Arne Reimers; Olav Spigset
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 2.  The biochemical basis of hereditary fructose intolerance.

Authors:  Nadia Bouteldja; David J Timson
Journal:  J Inherit Metab Dis       Date:  2010-02-17       Impact factor: 4.982

Review 3.  [Repeated perioperative administration of fructose and sorbitol in a female patient with hereditary fructose intolerance [HFI)].

Authors:  M Sachs; F Asskali; H Förster; A Encke
Journal:  Z Ernahrungswiss       Date:  1993-03

Review 4.  Early onset systemic lupus erythematosus: differential diagnoses, clinical presentation, and treatment options.

Authors:  Christian Michael Hedrich; Hildegard Zappel; Simon Straub; Martin W Laass; Kathrin Wieczorek; Gabriele Hahn; Georg Heubner; Manfred Gahr
Journal:  Clin Rheumatol       Date:  2010-10-01       Impact factor: 3.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.